These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17907263)

  • 1. Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.
    Roth T; Mayleben D; Corser BC; Singh NN
    Hum Psychopharmacol; 2008 Jan; 23(1):13-20. PubMed ID: 17907263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
    Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
    Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
    J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-bedtime dosing with indiplon in adults and the elderly: results from two placebo-controlled, active comparator crossover studies in healthy volunteers.
    Farber RH; Burke PJ
    Curr Med Res Opin; 2008 Mar; 24(3):837-46. PubMed ID: 18257978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
    Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
    Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
    Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
    J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual zolpidem (Edluar™; Sublinox™).
    Yang LP; Deeks ED
    CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
    Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
    Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
    Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.
    Mattila MJ; Nurminen ML; Vainio P; Vanakoski J
    Eur J Clin Pharmacol; 1998 Jul; 54(5):421-5. PubMed ID: 9754987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
    Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine.
    Cysneiros RM; Farkas D; Harmatz JS; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 2007 Jul; 82(1):54-62. PubMed ID: 17443132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.
    Blin O; Micallef J; Audebert C; Legangneux E
    J Clin Psychopharmacol; 2006 Jun; 26(3):284-9. PubMed ID: 16702893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a Novel Zolpidem Nasal Spray for Rapid Management of Insomnia: First Trial in Humans.
    Li CT; Su TP; Wang Y; Lee B; Toh M; Ho T
    J Clin Sleep Med; 2016 Nov; 12(11):1453-1459. PubMed ID: 27568900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
    Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
    Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
    Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.
    Blumer JL; Reed MD; Steinberg F; O'Riordan MA; Rosen CL; Springer MA; Christensen M; Glaze D;
    Clin Pharmacol Ther; 2008 Apr; 83(4):551-8. PubMed ID: 17957186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo.
    Allain H; Bentué-Ferrer D; Tarral A; Gandon JM
    Eur J Clin Pharmacol; 2003 Jul; 59(3):179-88. PubMed ID: 12756510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic and pharmacokinetic profile of SM-1, a triple-drug combination to increase total sleep time.
    Dahl T; Chen LB; Scheinin M; Suopanki-Lalowski J; Valge M; Puhakka A; Mikola H; Lovró Z; Meierjohann A; Vuorilehto L; Roth T
    Hum Psychopharmacol; 2019 Nov; 34(6):e2716. PubMed ID: 31794072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.